Avascular osteonecrosis of the jaw as a side effect of bisphosphonate treatment.
Aristotle
A
Bamias
Evangelos
E
Terpos
Meletios A
MA
Dimopoulos
D020533:Angiogenesis Inhibitors / Q000009:adverse effects / Q000627:therapeutic use; D050071:Bone Density Conservation Agents / Q000009:adverse effects* / Q000627:therapeutic use; D003430:Cross-Sectional Studies; D003729:Dental Care / Q000009:adverse effects; D004164:Diphosphonates / Q000009:adverse effects*; D004357:Drug Synergism; D006801:Humans; D007571:Jaw Diseases / Q000139:chemically induced*; D010020:Osteonecrosis / Q000139:chemically induced* / Q000453:epidemiology; D012307:Risk Factors
D020533:Angiogenesis Inhibitors; D050071:Bone Density Conservation Agents; D004164:Diphosphonates